Notice on Public Offering of Unsecured Subordinated Bonds 31-01-2023, 12:11

Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis 16-07-2024, 20:26

As part of the collective initiative “Monaco, Capital of Advanced Yachting” Yacht Club de Monaco welcomes S/Y Simena to the 2026 Day of Exploration 21-24 March 2026 13-03-2026, 16:58